The first respiratory syncytial virus vaccine has been licenced by the US Food and Drug Administration for use in pregnant women.

The first respiratory syncytial virus (RSV) vaccination has been licenced by the Food and Drug Administration…

FDA expands Pfizer COVID booster, opens extra dose to age 16

The US is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose…

FDA paves way for Pfizer Covid-19 vaccinations in young kids

The Food and Drug Administration (FDA) on October 29 paved the way for children ages 5…

AstraZeneca asks FDA to authorise COVID antibody treatment

London: AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the…